| Noncolorectal Gastrointestinal Cancer |
1 |
1 |
| Colorectal Cancer |
0 |
0.94 |
| Biologic Therapy |
0 |
0.88 |
| Otolaryngology |
0 |
0.88 |
| Cancer |
0 |
0.79 |
| Esophageal Cancer |
0 |
0.72 |
| Rectal Cancer |
0 |
0.7 |
| Colon Cancer |
0 |
0.67 |
| Gastrointestinal Cancer |
0 |
0.6 |
| Toxicology |
0 |
0.52 |
| Immunotherapy |
0 |
0.28 |
| KRAS |
0 |
0.24 |
| Neoadjuvant Therapy |
0 |
0.2 |
| Esophageal Adenocarcinoma |
0 |
0.17 |
| Esophagus |
0 |
0.16 |
| Surgery |
0 |
0.16 |
| Surgical Oncology |
0 |
0.15 |
| Chemotherapy |
0 |
0.12 |
| Perioperative Care |
0 |
0.12 |
| Adenocarcinoma |
0 |
0.08 |
| Medical Oncology |
0 |
0.99 |
| Microsatellite Instability |
0 |
0.08 |
| Pancreas |
0 |
0.08 |
| Tumor |
0 |
0.08 |
| Utah |
0 |
0.08 |